{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:45:43Z","timestamp":1793810743570,"version":"4.6.1"},"reference-count":37,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Norwegian National Centre for Ageing and Health","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The Norwegian Registry of Persons Assessed for Cognitive Symptoms (NorCog) was established to harmonise and improve the quality of diagnostic practice across clinics assessing persons with cognitive symptoms in Norwegian specialist healthcare units and to establish a large research cohort with extensive clinical data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>The registry recruits patients who are referred for assessment of cognitive symptoms and suspected dementia at outpatient clinics in Norwegian specialist healthcare units. In total, 18 120 patients have been included in NorCog during the period of 2009\u20132021. The average age at inclusion was 73.7 years. About half of the patients (46%) were diagnosed with dementia at the baseline assessment, 35% with mild cognitive impairment and 13% with no or subjective cognitive impairment; 7% received other specified diagnoses such as mood disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings to date<\/jats:title>\n                    <jats:p>All patients have a detailed baseline characterisation involving lifestyle and demographic variables; activities of daily living; caregiver situation; medical history; medication; psychiatric, physical and neurological examinations; neurocognitive testing; blood laboratory work-up; and structural or functional brain imaging. Diagnoses are set according to standardised diagnostic criteria. The research biobank stores DNA and blood samples from 4000 patients as well as cerebrospinal fluid from 800 patients. Data from NorCog have been used in a wide range of research projects evaluating and validating dementia-related assessment tools, and identifying patient characteristics, symptoms, functioning and needs, as well as caregiver burden and requirement of available resources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Future plans<\/jats:title>\n                    <jats:p>The finish date of NorCog was originally in 2029. In 2021, the registry\u2019s legal basis was reformalised and NorCog got approval to collect and keep data for as long as is necessary to achieve the purpose of the registry. In 2022, the registry underwent major changes. Paper-based data collection was replaced with digital registration, and the number of variables collected was reduced. Future plans involve expanding the registry to include patients from primary care centres.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-058810","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:35:55Z","timestamp":1662636955000},"page":"e058810","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Cohort profile: the Norwegian Registry of Persons Assessed for Cognitive Symptoms (NorCog) \u2013 a national research and quality registry with a biomaterial collection"],"prefix":"10.1136","volume":"12","author":[{"given":"Ingrid T\u00f8ndel","family":"Medb\u00f8en","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"N\u00e5vik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torunn Holm","family":"Totland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrine Selnes","family":"Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingun","family":"Ulstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Engedal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Brita","family":"Knapskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Br\u00e6khus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Rita","family":"\u00d8kseng\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Otto","family":"Horndalsveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild","family":"Saltvedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Liv","family":"Lyngroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette Hylen","family":"Ranhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagny Bekkeheien","family":"Skrettingland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena Zugic","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6511-8219","authenticated-orcid":false,"given":"Geir","family":"Selbaek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"2022110206454774000_12.9.e058810.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204436","article-title":"Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway","volume":"13","author":"Strand","year":"2018","journal-title":"PLoS One"},{"key":"2022110206454774000_12.9.e058810.2","unstructured":"Norwegian Directorate of Health . The Norwegian national guideline on dementia, IS-2658: Helsedirektoratet, 2017. Available: https:\/\/www.helsedirektoratet.no\/retningslinjer\/demens [Accessed 16 Aug 2017]."},{"key":"2022110206454774000_12.9.e058810.3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-180370","article-title":"Challenges for Optimizing Real-World Evidence in Alzheimer\u2019s Disease: The ROADMAP Project","volume":"67","author":"Gallacher","year":"2019","journal-title":"Journal of Alzheimer's Disease"},{"key":"2022110206454774000_12.9.e058810.4"},{"key":"2022110206454774000_12.9.e058810.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00186.x"},{"key":"2022110206454774000_12.9.e058810.6","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.11.0786"},{"key":"2022110206454774000_12.9.e058810.7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/JAD-150144","article-title":"Dementia diagnosis, treatment, and care in specialist clinics in two Scandinavian countries: a data comparison between the Swedish dementia registry (SveDem) and the Danish dementia registry","volume":"48","author":"Fereshtehnejad","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"2022110206454774000_12.9.e058810.8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3233\/JAD-201275","article-title":"Current and future prevalence estimates of mild cognitive impairment, dementia, and its subtypes in a population-based sample of people 70 years and older in Norway: the HUNT study","volume":"79","author":"Gj\u00d8ra","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"2022110206454774000_12.9.e058810.9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.140.6.566"},{"key":"2022110206454774000_12.9.e058810.10","article-title":"A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease","volume":"12","author":"Edwin","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2022110206454774000_12.9.e058810.11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1017\/S1041610220003270","article-title":"Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis","volume":"33","author":"Edwin","year":"2021","journal-title":"Int Psychogeriatr"},{"key":"2022110206454774000_12.9.e058810.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243513","article-title":"Time from dementia diagnosis to nursing-home admission and death among persons with dementia: a multistate survival analysis","volume":"15","author":"Mj\u00f8rud","year":"2020","journal-title":"PLoS One"},{"key":"2022110206454774000_12.9.e058810.13","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association . Diagnostic and statistical manual of mental disorders: DSM-5. 5th edn. Washington, D.C: American Psychiatric Publishing, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2022110206454774000_12.9.e058810.14","unstructured":"World Health Organization . The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva, 1993."},{"key":"2022110206454774000_12.9.e058810.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01380.x"},{"key":"2022110206454774000_12.9.e058810.16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging\u2010Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's & Dementia"},{"key":"2022110206454774000_12.9.e058810.17","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000034"},{"key":"2022110206454774000_12.9.e058810.18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004058"},{"key":"2022110206454774000_12.9.e058810.19","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21507"},{"key":"2022110206454774000_12.9.e058810.20","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr179"},{"key":"2022110206454774000_12.9.e058810.21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821103e6"},{"key":"2022110206454774000_12.9.e058810.22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging\u2010Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer's & Dementia"},{"key":"2022110206454774000_12.9.e058810.23","doi-asserted-by":"publisher","DOI":"10.1159\/000334983"},{"key":"2022110206454774000_12.9.e058810.24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000437298","article-title":"Burden of care and patient's neuropsychiatric symptoms influence carer's evaluation of cognitive impairment","volume":"40","author":"Persson","year":"2015","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2022110206454774000_12.9.e058810.25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/gps.4433","article-title":"Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer's disease","volume":"31","author":"Svendsboe","year":"2016","journal-title":"Int J Geriatr Psychiatry"},{"key":"2022110206454774000_12.9.e058810.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)00070-3"},{"key":"2022110206454774000_12.9.e058810.27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WAD.0000000000000126","article-title":"Performance of cerebrospinal fluid biomarkers of Alzheimer disease in a memory clinic in Norway","volume":"30","author":"Knapskog","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2022110206454774000_12.9.e058810.28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/WAD.0000000000000268","article-title":"The effect of changing the amyloid \u03b242 cut-off of cerebrospinal fluid biomarkers on Alzheimer disease diagnosis in a memory clinic population in Norway","volume":"33","author":"Knapskog","year":"2019","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2022110206454774000_12.9.e058810.29","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/0284185116669874","article-title":"Fully automated structural MRI of the brain in clinical dementia workup","volume":"58","author":"Persson","year":"2017","journal-title":"Acta Radiol"},{"key":"2022110206454774000_12.9.e058810.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211103"},{"key":"2022110206454774000_12.9.e058810.31","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3246"},{"key":"2022110206454774000_12.9.e058810.32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36429-6","article-title":"Meta-Analysis of Alzheimer's disease on 9,751 samples from Norway and IGAP study identifies four risk loci","volume":"8","author":"Witoelar","year":"2018","journal-title":"Sci Rep"},{"key":"2022110206454774000_12.9.e058810.33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-Wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat Genet"},{"key":"2022110206454774000_12.9.e058810.34","doi-asserted-by":"publisher","DOI":"10.1080\/02813432.2020.1753334"},{"key":"2022110206454774000_12.9.e058810.35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jalz.2017.04.005","article-title":"Dementia registries around the globe and their applications: a systematic review","volume":"13","author":"Krysinska","year":"2017","journal-title":"Alzheimers Dement"},{"key":"2022110206454774000_12.9.e058810.36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116538"},{"key":"2022110206454774000_12.9.e058810.37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/13607863.2010.508769","article-title":"Development of a dementia assessment quality database","volume":"15","author":"Johannsen","year":"2011","journal-title":"Aging Ment Health"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-058810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T09:58:25Z","timestamp":1667383105000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-058810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,8]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/bmjopen-2021-058810"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-058810","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}